Some mutations, such as TP53multihit, FLT3, MLLPTD, ASXL1, BCOR, EZH2, NRAS, RUNX1, STAG2, and U2AF1 show unfavorable outcomes regarding OS, LFS, and AML transformation. This evidence concerns the gene U2AF1 and acute myeloid leukemia.